BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10217622)

  • 1. Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects.
    Ventura FV; Costa CG; Struys EA; Ruiter J; Allers P; Ijlst L; Tavares de Almeida I; Duran M; Jakobs C; Wanders RJ
    Clin Chim Acta; 1999 Mar; 281(1-2):1-17. PubMed ID: 10217622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
    Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
    Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular in vitro probe acylcarnitine assay for identifying deficiencies of carnitine transporter and carnitine palmitoyltransferase-1.
    Purevsuren J; Kobayashi H; Hasegawa Y; Yamada K; Takahashi T; Takayanagi M; Fukao T; Fukuda S; Yamaguchi S
    Anal Bioanal Chem; 2013 Feb; 405(4):1345-51. PubMed ID: 23143007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.
    Okun JG; Kölker S; Schulze A; Kohlmüller D; Olgemöller K; Lindner M; Hoffmann GF; Wanders RJ; Mayatepek E
    Biochim Biophys Acta; 2002 Oct; 1584(2-3):91-8. PubMed ID: 12385891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders.
    Schmidt-Sommerfeld E; Bobrowski PJ; Penn D; Rhead WJ; Wanders RJ; Bennett MJ
    Pediatr Res; 1998 Aug; 44(2):210-4. PubMed ID: 9702916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
    Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
    Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
    Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
    Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
    Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
    Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
    Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
    Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylcarnitine profiles in fibroblasts from patients with respiratory chain defects can resemble those from patients with mitochondrial fatty acid beta-oxidation disorders.
    Sim KG; Carpenter K; Hammond J; Christodoulou J; Wilcken B
    Metabolism; 2002 Mar; 51(3):366-71. PubMed ID: 11887175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts.
    Manning NJ; Olpin SE; Pollitt RJ; Webley J
    J Inherit Metab Dis; 1990; 13(1):58-68. PubMed ID: 2109149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate induces in vitro accumulation of long-chain fatty acylcarnitines.
    Silva MF; Jakobs C; Duran M; de Almeida IT; Wanders RJ
    Mol Genet Metab; 2001 Aug; 73(4):358-61. PubMed ID: 11509020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
    Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
    Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
    Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle.
    Tyni T; Pourfarzam M; Turnbull DM
    Pediatr Res; 2002 Jul; 52(1):64-70. PubMed ID: 12084849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects.
    Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH
    J Inherit Metab Dis; 1999 May; 22(3):302-6. PubMed ID: 10384392
    [No Abstract]   [Full Text] [Related]  

  • 20. A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation.
    Seargeant LE; Balachandra K; Mallory C; Dilling LA; Greenberg CR
    J Inherit Metab Dis; 1999 Aug; 22(6):740-6. PubMed ID: 10472534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.